National Institute on Drug Abuse; Notice of Meeting, 20895-20896 [2014-08271]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 71 / Monday, April 14, 2014 / Notices
Blvd., Room 4229, MSC 9550, Bethesda, MD
20892–9550, 301–402–2105, rogersn2@
nida.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS).
Dated: April 8, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–08272 Filed 4–11–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel SBIR
Phase II: An In-situ Opioid Drug Deactivation
Kit for Home Use (4418).
Date: April 25, 2014.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Jose F. Ruiz, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, Room 4228, MSC 9550,
6001 Executive Blvd., Bethesda, MD 20892–
9550, (301) 451–3086, ruizjf@nida.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; SBIR
Phase II: At-Home Deactivation (4421).
Date: April 25, 2014
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
VerDate Mar<15>2010
17:39 Apr 11, 2014
Jkt 232001
Contact Person: Jose F. Ruiz, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, Room 4228, MSC 9550,
6001 Executive Blvd., Bethesda, MD 20892–
9550, (301) 451–3086, uizjf@nida.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; SBIR
Phase II Relapse Prevention (4417 & 4419).
Date: April 30, 2014.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Nadine Rogers, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Blvd., Room 4229, MSC 9550, Bethesda, MD
20892–9550, 301–402–2105, rogersn2@nida.
nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; GMP
Synthesis of Bulk Drug Substances (8915).
Date: May 28, 2014.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 435–1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS).
Dated: April 8, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–08270 Filed 4–11–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
20895
National Advisory Council on Drug
Abuse.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Drug Abuse.
Date: May 6–7, 2014.
Closed: May 6, 2014, 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Rooms C & D,
Rockville, MD 20852.
Open: May 7, 2014, 8:30 a.m. to 2:30 p.m.
Agenda: This portion of the meeting will
be open to the public for announcements and
reports of administrative, legislative and
program developments in the drug abuse
field.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Rooms C & D,
Rockville, MD 20852.
Contact Person: Mark Swieter, Ph.D.,
Acting Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4243, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 435–1389, ms80x@nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
E:\FR\FM\14APN1.SGM
14APN1
20896
Federal Register / Vol. 79, No. 71 / Monday, April 14, 2014 / Notices
Information is also available on the
Institute’s/Center’s home page:
www.drugabuse.gov/NACDA/
NACDAHome.html, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS).
Dated: April 8, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–08271 Filed 4–11–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development Amended; Notice of
Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Child Health and Human Development
Special Emphasis Panel, April 22, 2014,
2:00 p.m. to April 22, 2014, 4:00 p.m.,
National Institutes of Health, 6100
Executive Boulevard, Rockville, MD,
20852 which was published in the
Federal Register on March 27, 2014, 79
FR 17169. The meeting notice is
amended to change the date of the
meeting from April 22, 2014 to April 23,
2014. The meeting is closed to the
public.
Dated: April 8, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–08273 Filed 4–11–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2010–0164]
National Boating Safety Advisory
Council
Coast Guard, DHS.
Notice of Federal Advisory
Committee Meeting.
mstockstill on DSK4VPTVN1PROD with NOTICES
AGENCY:
ACTION:
The National Boating Safety
Advisory Council (NBSAC) will meet on
May 8–9, 2014, in Arlington, VA, to
discuss issues relating to recreational
boating safety. The meetings will be
open to the public.
SUMMARY:
VerDate Mar<15>2010
17:39 Apr 11, 2014
Jkt 232001
NBSAC will meet Thursday, May
8, 2014, from 9:00 a.m. to 5:00 p.m. and
Friday, May 9, 2014, from 9:00 a.m. to
12:00 p.m. Please note that the meetings
may conclude early if NBSAC has
completed all business.
ADDRESSES: The meeting will be held in
the Ballroom of the Holiday Inn
Arlington (https://www.hiarlington.com),
4610 N Fairfax Drive, Arlington, VA
22203.
For information on facilities or
services for individuals with disabilities
or to request special assistance at the
meeting, contact Mr. Jeff Ludwig,
Alternate Designated Federal Officer
(ADFO), telephone 202–372–1061, or at
Jeffrey.a.ludwig@uscg.mil.
To facilitate public participation, we
are inviting public comment on the
issues to be considered by the
committee as listed in the ‘‘Agenda’’
section below. Written comments for
distribution to Council members must
be submitted no later than April 30,
2014, and must be identified by (USCG–
2010–0164) and may be submitted by
one of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov.
Follow the instructions for submitting
comments (preferred method to avoid
delays in processing).
• Fax: (202) 372–1908.
• Mail: Docket Management Facility
(M–30), U.S. Department of
Transportation, West Building Ground
Floor, Room W12–140, 1200 New Jersey
Avenue SE., Washington, DC 20590–
0001.
• Hand Delivery: Same as mail
address above between 9 a.m. and 5
p.m., Monday through Friday, except
Federal holidays. The telephone number
is 202–366–9329.
Instructions: All submissions received
must include the words ‘‘Department of
Homeland Security’’ and the docket
number for this action. Comments
received will be posted without
alteration at https://www.regulations.gov,
including any personal information
provided. You may review a Privacy Act
notice regarding public dockets in the
January 17, 2008, issue of the Federal
Register (73 FR 3316).
Docket: For access to the docket to
read documents or comments related to
this notice, go to https://
www.regulations.gov, enter the docket
number in the ‘‘Search’’ field and follow
instructions on the Web site.
Public oral comment periods will be
held each day. Speakers are requested to
limit their comments to 3 minutes.
Please note that the public comment
periods may end before the time
indicated, following the last call for
DATES:
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
comments. Contact Mr. Jeffrey Ludwig
as indicated below to register as a
speaker.
Mr.
Jeff Ludwig, ADFO for NBSAC,
telephone (202) 372–1061, or at
jeffrey.a.ludwig@uscg.mil. If you have
questions on viewing or submitting
material to the docket, call Cheryl
Collins, Program Manager, Docket
Operations, telephone 202–366–9826.
SUPPLEMENTARY INFORMATION: Notice of
this meeting is given under the Federal
Advisory Committee Act (FACA), 5
U.S.C. Appendix 2. Congress
established NBSAC in the Federal Boat
Safety Act of 1971 (Pub. L. 92–75).
NBSAC currently operates under the
authority of 46 U.S.C. 13110, which
requires the Secretary of Homeland
Security and the Commandant of the
Coast Guard by delegation to consult
with NBSAC in prescribing regulations
for recreational vessels and associated
equipment, and on other major safety
matters. See 46 U.S.C. 4302(c) and
13110(c).
FOR FURTHER INFORMATION CONTACT:
Meeting Agenda
The agenda for the NBSAC meeting is
as follows:
Thursday, May 8, 2014
(1) Opening Remarks, Swearing-In of
New Members and Presentation of
Awards to Outgoing Members.
(2) Receipt and discussion of the
following reports:
(a) Chief, Office of Auxiliary and
Boating Safety, Update on the Coast
Guard’s implementation of NBSAC
Resolutions and Recreational Boating
Safety Program report.
(b) Alternate Designated Federal
Officer’s report concerning Council
administrative and logistical matters.
(3) Presentation and discussion on the
Uniform Certificate of Title Act—Vessel
(UCOTA–V).
(4) Presentation and discussion on the
Coast Guard’s life jacket carriage
requirements and exemptions found in
33 CFR 175.
(5) Presentation and discussion on the
Coast Guard’s progress in implementing
NBSAC’s Recommendation Regarding
the Development of New Life Jacket
Standards and Approval Processes for
Life Jackets.
(6) Receipt and Discussion of the
Strategic Planning Subcommittee report.
(7) Public comment.
Friday, May 9, 2014
(1) Receipt and Discussion of the
Boats and Associated Equipment and
Prevention through People
Subcommittee reports.
E:\FR\FM\14APN1.SGM
14APN1
]]>Agencies
[Federal Register Volume 79, Number 71 (Monday, April 14, 2014)]
[Notices]
[Pages 20895-20896]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-08271]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Council on Drug Abuse.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Drug Abuse.
Date: May 6-7, 2014.
Closed: May 6, 2014, 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Conference Rooms C & D, Rockville, MD 20852.
Open: May 7, 2014, 8:30 a.m. to 2:30 p.m.
Agenda: This portion of the meeting will be open to the public
for announcements and reports of administrative, legislative and
program developments in the drug abuse field.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Conference Rooms C & D, Rockville, MD 20852.
Contact Person: Mark Swieter, Ph.D., Acting Director, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 4243, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 435-1389, ms80x@nih.gov.
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
[[Page 20896]]
Information is also available on the Institute's/Center's home
page: www.drugabuse.gov/NACDA/NACDAHome.html, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS).
Dated: April 8, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-08271 Filed 4-11-14; 8:45 am]
BILLING CODE 4140-01-P
